HomeNDC LookupIngredientsPovidone Iodine › 00904-1103-09
povidone iodine 100 mg/mL Solution, 237 mL — NDC 00904-1103-09 package photo

povidone iodine 100 mg/mL Solution, 237 mL

by Major Pharmaceuticals · 237 mL in 1 BOTTLE (0904-1103-09)
NDC 00904-1103-09
🏷️ FDA NDC (as labeled) 0904-1103-09 billing pads the labeler segment with a zero
OTC On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 0904-1103-09
Product NDC 0904-1103
11-digit billing NDC 00904110309
NCPDP billing unit ML — per mL (volume)
Application # M003
SPL Set ID 1e5aed0c-bd51-4ac8-9877-71bf18050dfd
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2011-12-21
Marketing end 2029-08-08
Route TOPICAL
Dosage form SOLUTION
Substance POVIDONE-IODINE
GCN Seq No 007233
GCN 45334
HICL code 004265
Ingredient (HICL) Povidone-Iodine
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5B
Therapeutic class — specific (HIC3) Topical Preparations,Antibacterials
AHFS code 84:04.92.00
AHFS class Local Anti-Infectives, Miscellaneous
FDB label name POVIDONE-IODINE 10% SOLUTION
FDB brand name Povidone-Iodine
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 0904-1103-09 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00904-1103-09. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerMajor Pharmaceuticals
FDA applicationM003 (OTC MONOGRAPH DRUG)
Labeler code00904
First marketedDec 2011
Product typeHuman Otc Drug
Portfolio629 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name POVIDONE-IODINE 10% SOLUTION Ingredient Povidone-Iodine
📗 Our plain-language guide HelloPharmacist
  • Povidone-iodine is an antiseptic — it kills bacteria on the skin. You'll find it in a lot of different products: surgical scrubs, skin prep solutions and swabs used before procedur...
  • What is povidone-iodine actually used for?
  • The standard topical products are for external skin use only — keep them away from your eyes, ears, and mouth. That said, the 3M Skin and Nasal Antiseptic is specifically labeled f...
  • For first-aid use at home, you should not use povidone-iodine on a wound for more than 7 days unless a doctor or dentist tells you it's okay. If your wound isn't improving after a...
📖 Read our full Povidone-Iodine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 2968PHW8QP
    A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII 6OZP39ZG8H
    Polysorbate 80 is a synthetic emulsifier derived from sorbitol and oleic acid. It helps mix oil and water-based ingredients together in medications and improves how the product disperses in the body.
  • UNII 1Q73Q2JULR
    Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
  • UNII SE337SVY37
    A mineral salt used as a buffer to help maintain the medicine's pH level and prevent breakdown of active ingredients. It also acts as a thickening agent in liquid formulations.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescitric acid glycerin sodium citrate tween 80 disodium phosphate purified Water

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.014 $3.39 / 237 ml
Medicaid paysCMS SDUD · 12 mo $0.0354 $8.39 / 237 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2021 Jul 2022 Dec 2025 Aug 2026 $0.015 $0.012
▲ Up 21% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
povidone iodine 100 mg/mLthis 00904-1103-09 Major 237 ml $0.014 Availability likely
Povidone Iodine .1 g/mL 24385-0053-55 Amerisource 236 ml $0.014 Availability likely
Quality Choice Povidone Iodine 100 mg/mL 63868-0230-08 Chain 237 ml $0.017 FDA listed +20%
sunmark Povidone-Iodine Topical 1 g/100mL 49348-0622-37 Strategic 237 ml $0.018 FDA listed +29%
Leader Povidone-Iodine 10% Topical Solution 10 mg/mL 70000-0060-01 Cardinal 237 ml $0.021 Availability likely +44%
Foster and Thrive Povidone-Iodine 100 mg/mL 70677-1208-01 Strategic 237 ml $0.021 Availability likely +44%
First Aid Antiseptic 10 mg/mL 00363-0777-34 Walgreen 236 ml FDA listed
Walgreens 10 Povidone-Iodine Solution 100 mg/mL 00363-3736-10 WALGREEN 1 bottle FDA listed
Humco Povidone Iodine 100 mg/mL 00395-2325-16 Humco 473 ml FDA listed
Povidone Iodine 100 mg/mL 00395-9123-16 Humco 473 ml FDA listed
Povidone-Iodine 10 mg/mL 00924-5408-01 Acme 10 vials FDA listed
Povidone Iodine Solution First Aid Antiseptic 10 mg/mL 11344-0050-26 Nice-Pak 118 ml FDA listed
First Aid Antiseptic 10 mg/mL 11673-0003-34 Target 236.5 ml FDA listed
Rite Aid Povidone Iodine 100 mg/mL 11822-3775-07 Rite 237 ml FDA listed
First Aid Antiseptic 10 mg/mL 11822-9050-01 Rite 237 ml FDA listed
First Aid Antiseptic 10 mg/mL 21130-0891-34 Better 236 ml FDA listed
Povidone Iodine Prep Solution Sterile 100 mg/mL 34645-0013-01 Jianerkang 30 ml FDA listed
Povidone Iodine Topical Solution Paint 100 mg/mL 34645-1040-02 Jianerkang 59 ml FDA listed
Povidone Iodine Topical Solution Paint 100 mg/mL 34645-1041-01 Jianerkang 88.5 ml FDA listed
Povidone Iodine 10 mg/mL 34645-4059-06 Jianerkang 59 ml FDA listed
Povidone Iodine 10 mg/mL 34645-4188-06 Jianerkang 88.5 ml FDA listed
Povidone Iodine Prep 10 g/100g 34645-5503-00 Jianerkang 500 patches FDA listed
Povidone Iodine Prep 10 g/100g 34645-5504-00 Jianerkang 250 patches FDA listed
First Aid Antiseptic 10 mg/mL 36800-0011-34 Topco 237 ml FDA listed
HEB Povidone Iodine 100 mg/mL 37808-0232-98 H 237 ml FDA listed
Povidone-Iodine 10 mg/mL 37808-0624-34 H 237 ml FDA listed
Povidone-Iodine Prep 100 mg/mL 39892-0809-01 O&M 1.5 ml FDA listed
MediChoice PVP Prep 100 mg/mL 39892-0840-01 O&M 59 ml FDA listed
MediChoice PVP Prep Solution 100 mg/mL 39892-0841-01 O&M 118 ml FDA listed
MediChoice PVP Prep 100 mg/mL 39892-0842-01 O&M 237 ml FDA listed
First Aid Antiseptic 10 mg/mL 41250-0720-34 Meijer, 237 ml FDA listed
Publix Povidone Iodine 100 mg/mL 41415-0325-98 Publix 237 ml FDA listed
First Aid Antiseptic 10 mg/mL 49035-0050-34 Walmart 237 ml FDA listed
Povidone-Iodine 10 mg/mL 50332-0056-01 HART 10 vials FDA listed
Aplicare Povidone-Iodine 10 mg/mL 52380-0011-01 Aplicare 30 ml Discontinued
Aplicare Povidone-Iodine 10 mg/mL 52380-1905-00 Aplicare 60 ml FDA listed
Aplicare Povidone-Iodine 10 mg/mL 52380-2801-08 Aplicare 59 ml FDA listed
Aplicare Povidone-Iodine 10 mg/mL 52380-4801-08 Aplicare 118 ml FDA listed
MedPride Prep Solution Topical Antiseptic Microbicide 100 mg/mL 52410-4114-05 Shield 474 ml FDA listed
Povidone-Iodine Topical Antiseptic 10 mg/mL 53329-0939-04 Medline 118 ml FDA listed
DDM Povidone Iodine 100 mg/mL 53943-0325-98 Discount 237 ml FDA listed
First Aid Antiseptic 10 mg/mL 55319-0700-26 Family 118 ml FDA listed
First Aid Antiseptic 10 mg/mL 55910-0001-26 Old 118 ml FDA listed
Amsino 10 Povidone-Iodine Solution 3 4 Fluid Ounce 100 mg/mL 59050-0265-01 Changzhou 22 ml FDA listed
Moakang Povidone-Iodine Scrub Winged Sponges 100 mg/mL 59050-0267-00 Changzhou 122.17 ml FDA listed
Maokang Medical 10 Povidone Iodine 100 mg/mL 59050-0272-10 Changzhou 2.12 ml FDA listed
Povidone-Iodine Solution Sterile 100 mg/mL 59050-0554-11 Changzhou 30 ml FDA listed
Maokang Povidone-Iodine Paint Solution Antiseptic 100 mg/mL 59050-0561-00 Changzhou 59 ml FDA listed
Povidone-Iodine Paint Solution 100 mg/mL 59050-0651-43 Changzhou 89 ml FDA listed
Maokang Povidone Iodine 100 mg/mL 59050-0802-00 Changzhou 29.5 ml FDA listed
Maokang Povidone-Iodine Antiseptic 100 mg/mL 59050-0858-01 Changzhou 118 ml FDA listed
Lights Povidone Iodine Solution 1.18 g/118mL 61333-0201-01 Lights 118 ml FDA listed
Lights Povidone Iodine Solution 1.18 g/118mL 61333-0202-01 Lights 118 ml FDA listed
Lights Povindone Iodine Swabstick 1 g/100g 61333-0204-01 Lights 4.3 g FDA listed
PVP-I Pouch foil-foil 1 g/100mL 65517-0035-01 Dukal 500 pouches FDA listed
Prep Solution Topical Antiseptic Microbicide 100 mg/mL 67326-0350-04 Degasa 948 ml FDA listed
Betadine Solution 10 mg/mL 67618-0150-01 Atlantis 3780 ml FDA listed
Dynarex Povidone Iodine Prep Solution 10 mg/mL 67777-0141-31 Dynarex 48 bottles FDA listed
Premier Value Povidone Iodine 100 mg/mL 68016-0415-00 Chain 237 ml FDA listed
Povidone Iodine Prep 10 g/100mL 68786-0010-08 Sion 236 ml FDA listed
Povidone Iodine Prep 1 g/100mL 68786-0132-01 Sion 500 packets FDA listed
povidone-iodine 10% 10 mg/mL 69452-0483-93 BIONPHARMA 237 ml FDA listed
CliniClean Povidone-Iodine Solution Antiseptic 100 mg/g 69464-0801-75 HR 23 g FDA listed
CVS Povidone-Iodine 100 mg/mL 69842-0325-98 CVS 237 ml FDA listed
Povidone-Iodine 100 mg/mL 70000-0757-01 CARDINAL 237 ml FDA listed
First Aid Antiseptic 10 mg/mL 72288-0450-26 Amazon.com 118 ml FDA listed
First Aid Antiseptic 10 mg/mL 72476-0050-34 Retail 237 ml FDA listed
Konix Povidone Iodine Topical Antiseptic 100 mg/mL 73107-0009-01 TURKUAZ 120 ml FDA listed
equate First Aid Antiseptic 1 g/100mL 79903-0230-08 Walmart 237 ml FDA listed
Freskaro Povidone Iodine 100 mg/mL 82645-0325-16 Pharma 473 ml FDA listed
Povidone Iodine 100 mg/mL 82645-0907-16 Pharma 473 ml FDA listed
ADI Medical PVP-I Pouch, Foil 10 g/100g 83645-0550-11 Asia 50 pouches FDA listed
sterile 10 g/100g 83645-0552-11 Asia 22.5 g FDA listed
Povidone Iodine 10% 100 mg/mL 85786-0702-08 Farmacias 237 ml FDA listed
Proheal Povidone Iodine 1 g/100mL 86173-0004-04 Click 118 ml FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2011
On the market since
Dec 2011
📍
2026
Currently FDA-listed
15 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00904-1103-09, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
1.1K
Units reimbursed last 4 qtrs
281.5K
Gross reimbursed last 4 qtrs
$10K
Avg / prescription
$9.39
Avg / unit
$0.0354
Latest quarter Q4 2025
230Rx
Medicaid pays / mL
$0.0354
gross reimbursed
vs
NADAC / mL
$0.0143
acquisition cost
=
Spread
+$0.0211
+148% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
34% FFS 66% MCO
Fee-for-service · 358 Rx Managed care · 704 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 32,041 units · 558 per 100k residents MN Wisconsin: no data reported WI Michigan: 2,738 units · 27.3 per 100k residents MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 58,974 units · 470 per 100k residents IL Indiana: 51,157 units · 746 per 100k residents IN Ohio: 67,245 units · 571 per 100k residents OH Pennsylvania: 29,249 units · 226 per 100k residents PA New Jersey: 21,135 units · 228 per 100k residents NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: 5,669 units · 65.0 per 100k residents VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: 10,148 units · 707 per 100k residents HI Texas: 3,094 units · 10.1 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
10.1746
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Indiana 746 /100k
2 Hawaii 707 /100k
3 Ohio 571 /100k
4 Minnesota 558 /100k
5 Illinois 470 /100k
6 New Jersey 228 /100k
7 Pennsylvania 226 /100k
8 Virginia 65.0 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

📊 Medicare Part D spend CMS · PART D · 2025 (Q1-Q4)

Medicare Part D (outpatient prescription) spending for Betadine (matched by generic name) — the program that covers self-administered drugs. 1 manufacturer.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Betadine. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Total Part D spend
$874.18
Claims incl. refills
38
Beneficiaries
28
Spend / beneficiary
$31.22
Spend / claim
$23.00
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Povidone Iodine — the ingredient across all brands.

Top reported reactions

Endophthalmitis427
Drug Hypersensitivity382
Toxic Anterior Segment Syndrome284
Rash273
Nausea240
Pain216
Eye Pain201

Age at onset

Neonate13
Infant15
Child10
Adolescent6
Adult308
Elderly163

Reporter sex

4,216 reports
Male · 35%
Female · 65%
Unknown · 0%

Serious outcomes

Hospitalization1,315
Disabling295
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 262 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
00904-1103-09 You're viewing this 237 mL in 1 BOTTLE (0904-1103-09) 2011-12-21 Active

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 10 words

For use as an first aid antiseptic pre-operative skin preperation

⏱️ Dosage and Administration 51 words

Directions As a first aid antiseptic clean affected area apply a small amount of this product to the area1 to 3 times daily may be covered with a sterile bandage, if bandaged let dry. For preoperative patient skin preparation clean area apply to operative site prior to surgery using the applicator

⚠️ Warnings 5 words

Warnings FOR EXTERNAL USE ONLY

🧪 Active Ingredient 10 words

Active ingredient Active Ingredient Purpose Povidone Iodine 10% v/v Antiseptic

🧪 Inactive Ingredients 13 words

Inactive Ingredient citric acid glycerin sodium citrate tween 80 disodium phosphate purified Water

🎯 Purpose 34 words

Uses First aid antiseptic to help prevent infection in minor cuts, scrapes and burns. Healthcare antiseptic for preparation of the skin prior to surgery. Antiseptic cleanser for preparation of skin prior to an infection.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.